about
Nucleic acid-based approaches to STAT inhibitionProtein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancerIs retinol binding protein 4 a link between adiposity and cancer?SOCS, inflammation, and cancerModeling of tumor progression in NSCLC and intrinsic resistance to TKI in loss of PTEN expressionSTAT3 oligonucleotide inhibits tumor angiogenesis in preclinical models of squamous cell carcinomaEriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 SignalingTranscriptional activation of the suppressor of cytokine signaling-3 (SOCS-3) gene via STAT3 is increased in F9 REX1 (ZFP-42) knockout teratocarcinoma stem cells relative to wild-type cellsOptimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitorsHCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell linesHigh-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.Gene expression and biological processes influenced by deletion of Stat3 in pulmonary type II epithelial cells.An orthotopic murine model of sinonasal malignancy.Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice.Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses.STAT3 signaling: anticancer strategies and challenges.Immune biomarkers of anti-EGFR monoclonal antibody therapyPhosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samplesInhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.Receptor-tyrosine-kinase-targeted therapies for head and neck cancer.The molecular pathogenesis of head and neck cancer.JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.Signaling by vitamin A and retinol-binding protein in regulation of insulin responses and lipid homeostasis.Molecular parameters of head and neck cancer metastasis.Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinomaA combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.Heparanase induces signal transducer and activator of transcription (STAT) protein phosphorylation: preclinical and clinical significance in head and neck cancerSTAT1 Activation Is Enhanced by Cisplatin and Variably Affected by EGFR Inhibition in HNSCC CellsRegulation of let-7 and its target oncogenes (Review)Lack of toxicity of a STAT3 decoy oligonucleotide.Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening.Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neck.Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway ActivationEpigenetic regulator Lid maintains germline stem cells through regulating JAK-STAT signaling pathway activity.Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide.Systems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 statusTargeting proliferation and survival pathways in head and neck cancer for therapeutic benefit
P2860
Q26822830-1C4AB944-3E58-4866-B495-D80C20AF50FBQ26852215-A303A7DA-B776-4AC8-8618-CD75F7BF12EFQ26862707-838104E0-A323-43EA-A3D6-C093FC0ADD03Q26991808-3C4AA83B-1539-4A0C-B87E-124D95F76CEAQ28484612-C3E0A038-5E3A-4B47-9473-959EE4CCFF34Q28538302-CD9E43E0-67B7-4AC1-AFAF-F47854F5AD92Q28547447-B10266F1-2F2B-4735-8D34-98CF0785C006Q28552654-CCADBF93-33F1-4982-A7F8-34CE9EF1E9E1Q30176405-29B5C526-AAE5-4E0C-B2DB-6A715D772352Q30276422-E5AF6A12-A520-4313-9AFD-2F9F52780309Q30278790-E05C0B71-F6BD-4AAB-AB4E-B55E26A449CCQ30408290-A487FC4C-AC4E-4578-9532-B059FE715114Q33309487-AF6696A3-FFAE-4B5D-AB8B-6F81A9E5FB59Q33674587-10634C00-9866-45EE-BA99-1BEEFEADD5EFQ33854787-D084A349-E332-4C51-87B9-0C5D19C90B81Q34633681-656E2412-87D3-4720-A24F-B6FC656EF6ECQ34693808-CBB88642-3A19-4D8E-B268-80CEB24C33C4Q34715455-793CBB89-6B8D-4120-BCD7-076FECA67CEFQ34723594-A1CB6F5D-66F6-409C-B94A-EFF538A2B8E3Q34760619-FCCFA7B0-6EF9-48FD-AE93-71B8E0FE87FDQ34790902-D6A08E0E-7475-4A76-B4D0-BA33162EFBEFQ35013758-731F4CCF-14E1-46F3-958A-4A2E7CF11770Q35102025-F735D933-78CC-4ADB-8F55-B5D50C21839CQ35111736-89674D67-803B-4D14-AF57-E63C1752793AQ35214530-539763D2-0C65-48E7-90C7-5AC802E4EB91Q35478457-6EA2B0E9-2F7F-472F-9A11-1554BA05F5DEQ35585465-116530D8-BE1B-41BC-8B58-685BB30A2F52Q35745696-5C2E56F5-20FD-4615-ABD4-CE76401C9461Q35799771-3F928628-BEA6-4C63-A1B4-7D0179D8EE2AQ35838889-0B8DF755-F4F3-4EB1-AA5B-A64264D8228DQ36030906-DEF7015B-E2F8-4724-9146-AB2330E38C8EQ36076000-167C8C48-F449-44A9-A9B2-86A866466B1AQ36175325-5F700F40-2DFE-497B-AE9C-4252186A9C27Q36179596-2B0969F7-B738-4EC6-9DEC-642B3B13FF3CQ36220747-1875DC4A-80EC-4117-859F-B1C707AE1428Q36297745-30D801EF-5415-44C7-8830-91664A374E07Q36506699-C1E27437-D3C4-4934-BC87-EB8ACC6837FBQ36544047-9E2485FA-B341-4867-8B1C-586316527AD1Q36678582-51855EC6-25E1-4038-8FBA-8ECD293A4C3DQ36713669-ADD601B7-B580-4A75-8F84-F23BD4783C57
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
STAT3 as a therapeutic target in head and neck cancer
@ast
STAT3 as a therapeutic target in head and neck cancer
@en
STAT3 as a therapeutic target in head and neck cancer
@nl
type
label
STAT3 as a therapeutic target in head and neck cancer
@ast
STAT3 as a therapeutic target in head and neck cancer
@en
STAT3 as a therapeutic target in head and neck cancer
@nl
prefLabel
STAT3 as a therapeutic target in head and neck cancer
@ast
STAT3 as a therapeutic target in head and neck cancer
@en
STAT3 as a therapeutic target in head and neck cancer
@nl
P2093
P2860
P3181
P356
P1476
STAT3 as a therapeutic target in head and neck cancer
@en
P2093
Jennifer Rubin Grandis
Rebecca J Leeman
Vivian Wai Yan Lui
P2860
P304
P3181
P356
10.1517/14712598.6.3.231
P407
P577
2006-03-01T00:00:00Z